In this project, we seek to identify novel blood-based epigenomic biomarkers to be used in early childhood as: biomarkers of natural history of prenatal exposure to gestational diabetes (GDM) and for profiling risks of obesity and cardiometabolic phenotypes among children born to GDM mothers (Aim 1);and intervention biomarkers that can help to predict the success of an early-childhood lifestyle intervention aiming at preventing GDM-related metabolic sequelae later in life (Aim 2). We will leverage extant resources from two investigations in Tianjin, China, i.e., the Tianjin GDM longitudinal observational study (TGDM-O) and the Tianjin GDM lifestyle-intervention randomized controlled trial (TGDM- T), both of which have been funded by the European Foundation for the Study of Diabetes (EFSD).
In Aim 1, we will identify blood methylomic patterns in TGDM-O correlated with prenatal GDM exposure and/or that predict adverse post-natal trajectories of body weight, adiposity and cardiometabolic phenotypes up to 10 years of age. We will also dissect genetic influences on the methylome by conducting joint analysis of genome- wide genetic (GWAS) and methylomic (EWAS) data. To ensure generalizability, we will confirm our findings in three large independent cohorts in the US and Europe (i.e., Project Viva, Avon Longitudinal Study of Parents and Children [ALSPAC], and Born in Bradford).
In Aim 2, we will leverage the resources of the ongoing TGDM- T to identify child's blood methylomic profiles that are induced by a 3-year lifestyle intervention. We will test our hypothesis that post-intervention methylomic profiles will allow for differentiating children who will maintain positive effects on body weight and metabolic profiles 2 years after the end of the intervention from those who will lose its benefits or rebound. In both aims, we will perform bisulfite-pyrosequencing for technical validation of DNA methylation findings and mRNA analysis to test whether methylomic differences correlate to gene expression. This will be the first study to prospectively examine the effects of GDM on the child's methylome and metabolic health, as well as to determine whether the lasting success of an early-life intervention can be predicted by monitoring changes in methylomic biomarkers. If successful, our project may provide novel tools to guide early childhood interventions through early biomarker monitoring. These biomarkers would be eventually used to implement personalized measures among children with GDM exposure and enhance long-lasting benefits to obesity prevention.

Public Health Relevance

Gestational Diabetes Mellitus (GDM) is tightly linked to overweight and obesity and is now diagnosed in as many as 7% of pregnancies in the US. In this project, we will identify novel biomarkers that can reconstruct prenatal GDM exposure and profile future risks of childhood obesity and related cardiometabolic phenotypes. We will also measure the efficacy of a lifestyle intervention at both molecular and phenotype levels. Our results will generate new scientific knowledge that may pave the way for future efforts for the prevention of childhood obesity and cardiovascular diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK100790-01A1
Application #
8782759
Study Section
Kidney, Nutrition, Obesity and Diabetes Study Section (KNOD)
Program Officer
Linder, Barbara
Project Start
2014-08-01
Project End
2018-07-31
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
1
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Lsu Pennington Biomedical Research Center
Department
Type
Organized Research Units
DUNS #
City
Baton Rouge
State
LA
Country
United States
Zip Code
70808
Liu, Huikun; Zhang, Shuang; Wang, Leishen et al. (2016) Fasting and 2-hour plasma glucose, and HbA1c in pregnancy and the postpartum risk of diabetes among Chinese women with gestational diabetes. Diabetes Res Clin Pract 112:30-6
Zhao, Pei; Liu, Enqing; Qiao, Yijuan et al. (2016) Maternal gestational diabetes and childhood obesity at age 9-11: results of a multinational study. Diabetologia 59:2339-48
Wang, Tiange; Liu, Huikun; Wang, Leishen et al. (2016) Zinc-Associated Variant in SLC30A8 Gene Interacts With Gestational Weight Gain on Postpartum Glycemic Changes: A Longitudinal Study in Women With Prior Gestational Diabetes Mellitus. Diabetes 65:3786-3793
Zhang, Shuang; Liu, Huikun; Zhang, Cuiping et al. (2015) Maternal glucose during pregnancy and after delivery in women with gestational diabetes mellitus on overweight status of their children. Biomed Res Int 2015:543038
Wang, Tiange; Leng, Junhong; Li, Nan et al. (2015) Genetic Predisposition to Polycystic Ovary Syndrome, Postpartum Weight Reduction, and Glycemic Changes: A Longitudinal Study in Women With Prior Gestational Diabetes. J Clin Endocrinol Metab 100:E1560-7
Leng, Junhong; Li, Weiqin; Zhang, Shuang et al. (2015) GDM Women's Pre-Pregnancy Overweight/Obesity and Gestational Weight Gain on Offspring Overweight Status. PLoS One 10:e0129536
Xiao, Yanyu; Qiao, Yijuan; Pan, Lei et al. (2015) Trends in the Prevalence of Overweight and Obesity among Chinese Preschool Children from 2006 to 2014. PLoS One 10:e0134466
Li, W; Liu, H; Qiao, Y et al. (2015) Metabolic syndrome of weight change from pre-pregnancy to 1-5 years post-partum among Chinese women with prior gestational diabetes. Diabet Med 32:1492-9